Tadahisa Sugiura1, Shuhei Tara1, Hidetaka Nakayama2, Tai Yi1, Yong-Ung Lee1, Toshihiro Shoji1, Christopher K Breuer1, Toshiharu Shinoka3. 1. Tissue Engineering Program and Surgical Research, Nationwide Children's Hospital, Columbus, Ohio. 2. QOL Research Center Laboratory, Gunze Limited, Ayabe-shi, Kyoto, Japan. 3. Tissue Engineering Program and Surgical Research, Nationwide Children's Hospital, Columbus, Ohio; Department of Cardiothoracic Surgery, The Heart Center, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: toshiharu.shinoka@nationwidechildrens.org.
Abstract
OBJECTIVE: Bioresorbable vascular grafts are biologically active grafts that are entirely reconstituted by host-derived cells through an inflammation-mediated degradation process. Calcification is a detrimental condition that can severely affect graft performance. Therefore, prevention of calcification is of great importance to the success of bioresorbable arterial vascular grafts. The objective of this study was to test whether fast-degrading (FD) bioresorbable arterial grafts with high cellular infiltration will inhibit calcification of grafts. METHODS: We created two versions of bioresorbable arterial vascular grafts, slow-degrading (SD) grafts and FD grafts. Both grafts had the same inner layer composed of a 50:50 poly(l-lactic-co-ε-caprolactone) copolymer scaffold. However, the outer layer of SD grafts was composed of poly(l-lactic acid) nanofiber, whereas the outer layer of FD grafts was composed of a combination of poly(l-lactic acid) and polyglycolic acid nanofiber. Both grafts were implanted in 8- to 10-week-old female mice (n = 15 in the SD group, n = 10 in the FD group) as infrarenal aortic interposition conduits. Animals were observed for 8 weeks. RESULTS: von Kossa staining showed calcification in 7 of 12 grafts in the SD group but zero in the FD group (P < .01, χ2 test). The cell number in the outer layer of FD grafts was significantly higher than in the SD grafts (SD, 0.87 ± 0.65 × 103/mm2; FD, 2.65 ± 1.91 × 103/mm2; P = .02). CONCLUSIONS: The FD bioresorbable arterial vascular graft with high cellular infiltration into the scaffold inhibited calcification of grafts.
OBJECTIVE: Bioresorbable vascular grafts are biologically active grafts that are entirely reconstituted by host-derived cells through an inflammation-mediated degradation process. Calcification is a detrimental condition that can severely affect graft performance. Therefore, prevention of calcification is of great importance to the success of bioresorbable arterial vascular grafts. The objective of this study was to test whether fast-degrading (FD) bioresorbable arterial grafts with high cellular infiltration will inhibit calcification of grafts. METHODS: We created two versions of bioresorbable arterial vascular grafts, slow-degrading (SD) grafts and FD grafts. Both grafts had the same inner layer composed of a 50:50 poly(l-lactic-co-ε-caprolactone) copolymer scaffold. However, the outer layer of SD grafts was composed of poly(l-lactic acid) nanofiber, whereas the outer layer of FD grafts was composed of a combination of poly(l-lactic acid) and polyglycolic acid nanofiber. Both grafts were implanted in 8- to 10-week-old female mice (n = 15 in the SD group, n = 10 in the FD group) as infrarenal aortic interposition conduits. Animals were observed for 8 weeks. RESULTS:von Kossa staining showed calcification in 7 of 12 grafts in the SD group but zero in the FD group (P < .01, χ2 test). The cell number in the outer layer of FD grafts was significantly higher than in the SD grafts (SD, 0.87 ± 0.65 × 103/mm2; FD, 2.65 ± 1.91 × 103/mm2; P = .02). CONCLUSIONS: The FD bioresorbable arterial vascular graft with high cellular infiltration into the scaffold inhibited calcification of grafts.
Authors: Sarra de Valence; Jean-Christophe Tille; Damiano Mugnai; Wojciech Mrowczynski; Robert Gurny; Michael Möller; Beat H Walpoth Journal: Biomaterials Date: 2011-09-21 Impact factor: 12.479
Authors: Tamar L Mirensky; Gregory N Nelson; Matthew P Brennan; Jason D Roh; Narutoshi Hibino; Tai Yi; Toshiharu Shinoka; Christopher K Breuer Journal: J Pediatr Surg Date: 2009-06 Impact factor: 2.545
Authors: Jason D Roh; Rajendra Sawh-Martinez; Matthew P Brennan; Steven M Jay; Lesley Devine; Deepak A Rao; Tai Yi; Tamar L Mirensky; Ani Nalbandian; Brooks Udelsman; Narutoshi Hibino; Toshiharu Shinoka; W Mark Saltzman; Edward Snyder; Themis R Kyriakides; Jordan S Pober; Christopher K Breuer Journal: Proc Natl Acad Sci U S A Date: 2010-03-05 Impact factor: 11.205
Authors: Shuhei Tara; Hirotsugu Kurobe; Mark W Maxfield; Kevin A Rocco; Tai Yi; Yuji Naito; Christopher K Breuer; Toshiharu Shinoka Journal: J Vasc Surg Date: 2014-04-16 Impact factor: 4.268
Authors: Takuma Fukunishi; Cameron A Best; Chin Siang Ong; Tyler Groehl; James Reinhardt; Tai Yi; Hideki Miyachi; Huaitao Zhang; Toshiharu Shinoka; Christopher K Breuer; Jed Johnson; Narutoshi Hibino Journal: Tissue Eng Part A Date: 2017-06-13 Impact factor: 3.845
Authors: Cansu Karakaya; Jordy G M van Asten; Tommaso Ristori; Cecilia M Sahlgren; Sandra Loerakker Journal: Biomech Model Mechanobiol Date: 2021-10-06
Authors: Yen-Lin Wu; Jason M Szafron; Kevin M Blum; Jacob C Zbinden; Ramak Khosravi; Cameron A Best; James W Reinhardt; Qiang Zeng; Tai Yi; Toshiharu Shinoka; Jay D Humphrey; Christopher K Breuer; Yadong Wang Journal: Tissue Eng Part A Date: 2020-09-30 Impact factor: 3.845
Authors: Kee-Won Lee; Piyusha S Gade; Liwei Dong; Zhaoxiang Zhang; Ali Mubin Aral; Jin Gao; Xiaochu Ding; Chelsea E T Stowell; Muhammad Umer Nisar; Kang Kim; Dieter P Reinhardt; Mario G Solari; Vijay S Gorantla; Anne M Robertson; Yadong Wang Journal: Biomaterials Date: 2018-07-26 Impact factor: 12.479
Authors: Renee Duijvelshoff; Nicole C A van Engeland; Karen M R Gabriels; Serge H M Söntjens; Anthal I P M Smits; Patricia Y W Dankers; Carlijn V C Bouten Journal: Bioengineering (Basel) Date: 2018-08-06